ADC Therapeutics S.A.ADCTNYSE
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
27.68%
↑ 234% above average
Average (30q)
-20.62%
Historical baseline
Range
High:83.94%
Low:-286.38%
Volatility
-1796.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 27.68% |
| Q2 2025 | -46.74% |
| Q1 2025 | -25.63% |
| Q4 2024 | 30.12% |
| Q3 2024 | -20.32% |
| Q2 2024 | 21.59% |
| Q1 2024 | 45.19% |
| Q4 2023 | -77.86% |
| Q3 2023 | 2.28% |
| Q2 2023 | 17.60% |
| Q1 2023 | -145.78% |
| Q4 2022 | 52.27% |
| Q3 2022 | 21.38% |
| Q2 2022 | -286.38% |
| Q1 2022 | 51.54% |
| Q4 2021 | 51.95% |
| Q3 2021 | 1.41% |
| Q2 2021 | -40.84% |
| Q1 2021 | 7.87% |
| Q4 2020 | -175.13% |
| Q3 2020 | 83.94% |
| Q2 2020 | -191.10% |
| Q1 2020 | -23.21% |
| Q4 2019 | -12.58% |
| Q3 2019 | -34.23% |
| Q2 2019 | 6.34% |
| Q1 2019 | 18.62% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.91% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |